HOOK Berita Valas

Hookipa Pharma Says Gilead Purchases Addl. 15 Mln Shares Of HOOKIPA For Total Stake Of About 19.4%

Immunotherapeutics company Hookipa Pharma Inc. (HOOK) announced Thursday that Gilead Sciences, Inc. (GILD) has purchased 15 million shares of HOOKIPA's common stock for approximately $21.25 million, at a price of $1.4167 per share.

RTTNews | 611 days ago

HOOKIPA Pharma Promotes Katia Schlienger As Chief Medical Officer

Biopharmaceutical company HOOKIPA Pharma Inc. (HOOK) announced Thursday the promotion of Katia Schlienger, to Chief Medical Officer and the appointment of Malte Peters, to its Board of Directors, both effective January 1, 2023.

RTTNews | 982 days ago

Terms | Privacy | Site Map | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.17215	GBPUSD	1.35266	AUDUSD	0.64914
USDJPY	146.942	USDCAD	1.38264	USDCHF	0.80144